Zonova is a UK-based antimicrobial materials company developing embedded antimicrobial technologies for medical devices. Founded in 2023, the company’s proprietary platform integrates antimicrobial protection directly into polymers to prevent microbial colonisation and biofilm formation without relying on antibiotics or toxic leaching compounds. Zonova partners with medical device manufacturers through a scalable licensing model designed to accelerate infection-resistant innovation across global healthcare systems.
Zonova
- Health
- London, United Kingdom
- £2.1m
- zonovatech.com
- Update Information
More venture news
- 3 Sept 2026

StrolllStrolll secures £4.3m in funding from Innovate UK and IW Capital for augmented reality neurorehabilitation
EquityHealth - 1 Sept 2026

HealfHealf secures funding led by SEMCAP Beauty & Wellness to expand its personalised wellbeing platform
EquityHealth - 11 Mar 2025

StrolllStrolll raises £10m Series A led by IW Capital to expand AR-based neurorehabilitation
Series AHealth
